Trinity Biotech (TRIB) has made significant progress in its continuous glucose monitor (CGM) technology. The company recently received a European patent for a process that enhances the performance of its glucose biosensor, leading to faster and more accurate glucose readings. This development, coupled with the growing CGM market, positions Trinity Biotech for future success.